Omics Technologies (0758.438.050): financials and annual accounts

Omics Technologies

Woluwe-Saint-Lambert ·KBO/BCE: BE 0758.438.050

Line	2025	2024	2023	2022	2021
Balance sheet: assets
Total assets`20/58`	58,867	36,269	38,953	50,022	85,354
Fixed assets`21/28`	235	235	511	1,061	1,612
Tangible fixed assets`22/27`	-	-	276	826	1,377
Furniture and vehicles`24`	-	-	276	826	1,377
Financial fixed assets`28`	235	235	235	235	235
Current assets`29/58`	58,632	36,034	38,442	48,961	83,742
Stocks and contracts in progress`3`	15,317	22,192	22,192	22,192	22,940
Stocks`30/36`	15,317	22,192	22,192	22,192	22,940
Amounts receivable within one year`40/41`	14,664	13,810	16,232	26,440	58,952
Trade receivables`40`	10,905	10,905	10,905	7,905	44,012
Other amounts receivable`41`	3,759	2,905	5,327	18,534	14,940
Cash at bank and in hand`54/58`	28,650	32	19	329	1,850
Balance sheet: equity and liabilities
Total equity and liabilities`10/49`	58,867	36,269	38,953	50,022	85,354
Equity`10/15`	16,715	14,942	21,622	36,901	41,526
Profit (loss) carried forward`14`	16,715	14,942	21,622	36,901	41,526
Amounts payable`17/49`	42,151	21,327	17,331	13,122	43,828
Amounts payable within one year`42/48`	42,151	21,327	17,331	13,122	43,828
Trade debts`44`	29,222	7,455	17,331	13,122	18,992
Suppliers`440/4`	29,222	7,455	17,331	13,122	18,992
Taxes, remuneration and social security`45`	-	-	-	-	10,382
Taxes`450/3`	-	-	-	-	10,382
Other amounts payable`47/48`	12,930	13,872	-	-	14,455
Income statement
Turnover`70`	-	-	-	-	155,078
Gross operating margin`9900`	3,544	-4,452	-12,983	-5,084	52,256
Goods, raw materials, services and sundry goods`60/61`	-	-	-	5,734	102,822
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets`630`	-	276	551	551	275
Other operating charges`640/8`	1,663	1,842	1,636	-	10
Operating profit (loss)`9901`	1,881	-6,570	-15,170	-5,635	51,971
Financial income`75/76B`	-	-	-	1,117	-
Recurring financial income`75`	-	-	-	1,117	-
Financial charges`65/66B`	108	110	108	108	63
Recurring financial charges`65`	108	110	108	108	63
Profit (loss) for the period before taxes`9903`	1,773	-6,680	-15,278	-4,626	51,908
Income taxes`67/77`	-	-	-	-	10,382
Profit (loss) for the period`9904`	1,773	-6,680	-15,278	-4,626	41,526
Profit (loss) for the period to be appropriated`9905`	1,773	-6,680	-15,278	-4,626	41,526
Appropriation of the result
Profit (loss) to be appropriated`9906`	16,715	14,942	21,622	36,901	41,526
Profit (loss) brought forward from the previous period`14P`	14,942	21,622	36,901	41,526	-
Document	PDF	PDF	PDF	PDF	PDF

Financial year	Type	Filed	Reference	Document
31-12-2025	micro format	08-07-2026	2026-00292534	PDF
31-12-2024	micro format	17-07-2025	2025-00281729	PDF
31-12-2023	micro format	31-08-2024	2024-00441301	PDF
31-12-2022	micro format	27-08-2023	2023-00399885	PDF
31-12-2021	micro format	19-10-2022	2022-20468225	PDF

Line	2025	2024	2023	2022	2021
EBITDA	-	-6,294	-14,619	-5,084	52,246
Cash flow	-	-6,404	-14,727	-4,075	41,802
Investment in fixed assets (approximation)	-	0	0	0	1,888
Change in cash	28,618	13	-311	-1,520	-
Working capital	16,480	14,707	21,112	35,839	39,914
EBIT margin	-	-	-	-	33.5%
Solvency	28.4%	41.2%	55.5%	73.8%	48.7%
Current ratio	1.39	1.69	2.22	3.73	1.91
Quick ratio	1.03	0.65	0.94	2.04	1.39
Debt to equity	2.52	1.43	0.80	0.36	1.06
ROE	10.6%	-44.7%	-70.7%	-12.5%	100.0%
ROA	3.0%	-18.4%	-39.2%	-9.2%	48.7%
Interest coverage	-	-57.04	-135.36	-47.07	over 100
Customer credit	-	-	-	-	104 days
Supplier credit	-	-	-	835 days	67 days

Item	2025	2024	2023	2022	2021
Tangible fixed assets	-	-	-	-	€1,653
Financial fixed assets	-	-	-	-	€235
Depreciation and write-downs of the year	-	€276	€551	€551	€275

Omics Technologies

Annual accounts 2025

Money flows

Balance sheet

Change in equityin euro

Change in cashin euro

Position in the sector

Solvency28.4%

Current ratio1.39

Return on assets3.0%

Filed annual accounts

Filings

Key figures and ratios

Investments

Insights on Omics Technologies

Next steps